The State of Texas has sued pharmaceutical firm Eli Lilly & Firm Inc., alleging the corporate engaged in improper practices to affect medical suppliers to prescribe its most commercially profitable medication, together with the GLP-1 medicines Mounjaro and Zepbound, that are indicated for weight reduction and diabetes administration.
Trending
- It’s goodnight Vienna as Paris sleeper train to Austria and Berlin hit by cuts | Rail transport
- How the MCM Comic Con Scholarship is empowering new creators
- Threads is Hiding Hashtags in Cross-Posts from Instagram
- Half of UK adults now pay on mobile
- 10 Stunning Anarkali suits for the festive season: Now at jaw-dropping prices on Amazon
- 10 Iconic Nicole Kidman Performances That Define Her Career
- Outperform Your Traditional 4K HMI Lights With the Powerful, New Godox MG4K
- Trump pulls pick to lead US jobs data agency
Texas Sues Eli Lilly: ‘Big Pharma Compromised Medical Decision-Making’
